A bone morphogenetic protein signaling inhibitor, LDN193189, converts ischemia-induced multipotent stem cells into neural stem/progenitor cell-like cells.
Sign Up to like & getrecommendations! Published in 2022 at "Stem cells and development"
DOI: 10.1089/scd.2022.0139
Abstract: Stem cell therapy is used to restore neurological function in stroke patients. We have previously reported that ischemia-induced multipotent stem cells (iSCs), which are likely derived from brain pericytes, develop in post-stroke human and mouse… read more here.
Keywords: ischemia induced; multipotent stem; induced multipotent; iscs ... See more keywords